Cargando…

Double-stranded RNA induction asa potential dynamic biomarkerfor DNA-demethylating agents

Hypomethylating agents (HMAs), such as azacitidine and decitabine, induce cancer cell death by demethylating DNAs to promote the expression of tumor-suppressor genes. HMAs also reactivate the transcription of endogenous double-stranded RNAs (dsRNAs) that trigger the innate immune response and subseq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Minjeong, Kharbash, Raisa, Byun, Ja Min, Jeon, Jaemin, Ali, Ahsan Ausaf, Ku, Doyeong, Yoon, Jimin, Ku, Yongsuk, Sohn, Jooyeon, Lee, Seung-Jae V., Shin, Dong-Yeop, Koh, Youngil, Yoon, Sung-Soo, Hong, Junshik, Kim, Yoosik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385881/ https://www.ncbi.nlm.nih.gov/pubmed/36035755 http://dx.doi.org/10.1016/j.omtn.2022.07.014

Ejemplares similares

Spiropyran as a potential molecular diagnostic tool for double-stranded RNA detection
por: Ali, Ahsan Ausaf, et al.
Publicado: (2019)

Resveratrol Attenuates the Mitochondrial RNA-Mediated Cellular Response to Immunogenic Stress
por: Yoon, Jimin, et al.
Publicado: (2023)

Analysis of mitochondrial double-stranded RNAs in human cells
por: Kim, Sujin, et al.
Publicado: (2023)

P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS
por: Min Byun, Ja, et al.
Publicado: (2023)

Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
por: Park, Hyunkyung, et al.
Publicado: (2020)

Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma
por: Park, Songyi, et al.
Publicado: (2021)

Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
por: Seo, Jeongmin, et al.
Publicado: (2021)

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM
por: Park, Hyunkyung, et al.
Publicado: (2022)

Mitochondrial double-stranded RNAs as a pivotal mediator in the pathogenesis of Sjӧgren’s syndrome
por: Yoon, Jimin, et al.
Publicado: (2022)

Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
por: Nam, Chang Hyun, et al.
Publicado: (2021)

Serum Erythropoietin level in anemia of elderly with unclear etiology
por: Seong, Ju Yong, et al.
Publicado: (2023)

Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation
por: Park, Woochan, et al.
Publicado: (2023)

Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients
por: Ahn, Hyun Jin, et al.
Publicado: (2022)

Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis
por: Kim, Dong Hyun, et al.
Publicado: (2022)

Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high‐risk multiple myeloma in Asian patients
por: Byun, Ja Min, et al.
Publicado: (2018)

Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?
por: Byun, Ja Min, et al.
Publicado: (2021)

Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment
por: Lee, Chansub, et al.
Publicado: (2022)

Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms
por: Kim, Jinyong, et al.
Publicado: (2021)

Asa Hill
Publicado: (1875)

PB1859: DNMT3A MUTATION PATTERNS AND CLINICAL FEATURES IN KOREAN ACUTE MYELOID LEUKEMIA PATIENTS
por: Lee, Eunyoung, et al.
Publicado: (2023)

Epigenetic priming improves salvage chemotherapy in diffuse large B-cell lymphoma via endogenous retrovirus-induced cGAS-STING activation
por: Liu, Jun, et al.
Publicado: (2023)

RTK-RAS pathway mutation is enriched in myeloid sarcoma
por: Choi, Mihong, et al.
Publicado: (2018)

2019 ASAS Meetings
Publicado: (2019)

Dr. Asa S. Couch
Publicado: (1917)

ASA Fiziksel Durum Sınıflandırma Sistemi: ASA Physical Status Classification System,
por: Günaydın, Berrin
Publicado: (2021)

MRI in axial spondyloarthritis: understanding an ‘ASAS-positive MRI’ and the ASAS classification criteria
por: Diekhoff, Torsten, et al.
Publicado: (2022)

High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic Malignancy
por: Kim, Eun Young, et al.
Publicado: (2020)

Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype
por: Kim, Sang-A, et al.
Publicado: (2018)

Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration
por: Liu, Jun, et al.
Publicado: (2020)

Dr. William Asa Wheeler
Publicado: (1912)

Dr. Asa W. Jayne
Publicado: (1908)

Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome
por: Choi, Mihong, et al.
Publicado: (2020)

Interaction of pAsa5 and pAsa8 Plasmids in Aeromonas salmonicida subsp. salmonicida
por: Marcoux, Pierre-Étienne, et al.
Publicado: (2023)

Metabolic Profiling during Acute Myeloid Leukemia Progression Using Paired Clinical Bone Marrow Serum Samples
por: Kim, Hyun Kyu, et al.
Publicado: (2021)

Multi-targeted therapy resistance via drug-induced secretome fucosylation
por: Aldonza, Mark Borris D, et al.
Publicado: (2023)

Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies
por: Lee, Eunyoung, et al.
Publicado: (2021)

Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
por: Lee, Ahreum, et al.
Publicado: (2020)

Concomitant ruxolitinib with cytarabine-based induction chemotherapy in secondary acute myeloid leukemia evolving from myeloproliferative neoplasm
por: Kim, Dong Hyun, et al.
Publicado: (2023)

Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer
por: Ku, Jayoung, et al.
Publicado: (2020)

Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia
por: Han, Heejoo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ckfp525i0pbhui4hdbi4sjrro1